Irinotecan plus fluorouracil and folinic acid should be the comparator regimen in clinical trials involving patients with metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Irinotecan cost effective in metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer

By Méndez M.   Alfonso P.   Pujol E.   González E.   Castañon C.   Cerezuela P.   López-Mateos Y.   Cruz J.  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 243-251

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

By Vincenzi Bruno   Santini Daniele   Russo Antonio   Gavasci Michele   Battistoni Fabrizio   Dicuonzo Giordano   Rocci Laura   Rosaria Valerio Maria   Gebbia Nicola   Tonini Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 319-327

Future Medicine

Access to resources Recommend Favorite